[Construction of GPI-CTLA4Ig chimeric molecule and its expression on CHO-dhfr(-) cells].
Journal: 2016/April - Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology
ISSN: 1007-8738
PUBMED: 15155072
Abstract:
OBJECTIVE
To develop a novel immunosuppressant GPI-CTLAIg modified by glycosyl-phosphatidylinositol(GPI).
METHODS
GPI-modified CTLAIg was produced by linking-up of CTLA4Ig with GPI-modification signal sequences from decay-accelerating factor (DAF). Chimeric molecule GPI-CTLA4Ig gene was cloned into eukaryotic expression vector pCI-dhfr. Using lipofectine-mediated gene transfer technique, pCI-GPI-CTLA4Ig was transfected into CHO-dhfr(-) cells, and the transfectants were screened by methotrexate (MTX). Expression of the recombinant protein was assessed by RT-PCR, ELISA, cell immunofluorescence staining and Western blot, and the purification of expressed protein was performed by protein A affinity chromatography.
RESULTS
The chimeric molecule GPI-CTLA4Ig has been constructed and stablely expressed on CHO-dhfr(-) cells.
CONCLUSIONS
GPI-modified CTLAIg will may be used as novel immunosuppressant for suppressing reaction in graft rejection.
Relations:
Chemicals
(3)
Organisms
(2)
Anatomy
(1)
Affiliates
(1)
Similar articles
Articles by the same authors
Discussion board
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.